Nuzenio

Psma

Psma news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 8 latest news signals 6 publisher sources 100/100 entity strength

Latest news

Shilpa Gupta: Excited to See the PSMAddition Trial Published - OncodailyOncodaily · Sat, 08 Aug 2026 22:07:21 GMT FDA approves Pluvicto for PSMA+ metastatic hormone-sensitive prostate cancer (mHSPC), advancing potential new standard of care across metastatic disease - NovartisNovartis · Sat, 08 Aug 2026 12:24:46 GMT PSMA PET Interpretation in Biochemical Recurrence After Prostate Cancer Treatment - Steve Cho - UroTodayUroToday · Fri, 07 Aug 2026 21:49:26 GMT Radiopharmaceutical may benefit patients with metastatic prostate cancer sooner - Medical XpressMedical Xpress · Fri, 07 Aug 2026 17:20:05 GMT TLX591 Antibody-Based Lutetium-177 PSMA Therapy in Metastatic CRPC - Pedro Barata - UroTodayUroToday · Thu, 06 Aug 2026 01:09:35 GMT FDA Approved Pluvicto Plus ARPI for PSMA-Positive mAPMN/S Prostate Cancer - OncodailyOncodaily · Wed, 05 Aug 2026 10:28:25 GMT Why You Might Need a PSMA PET Scan for Advanced Prostate Cancer - Cleveland Clinic Health EssentialsCleveland Clinic Health Essentials · Tue, 04 Aug 2026 04:15:13 GMT FDA Expands Approval of Pluvicto in Combination with ARPI for PSMA-Positive mAPMN/S Prostate Cancer - diagnosticimaging.comdiagnosticimaging.com · Sat, 01 Aug 2026 13:16:50 GMT

Timeline

Sat, 08 Aug 2026 22:07:21 GMTShilpa Gupta: Excited to See the PSMAddition Trial Published - Oncodaily

Sat, 08 Aug 2026 12:24:46 GMTFDA approves Pluvicto for PSMA+ metastatic hormone-sensitive prostate cancer (mHSPC), advancing potential new standard of care across metastatic disease - Novartis

Fri, 07 Aug 2026 21:49:26 GMTPSMA PET Interpretation in Biochemical Recurrence After Prostate Cancer Treatment - Steve Cho - UroToday

Fri, 07 Aug 2026 17:20:05 GMTRadiopharmaceutical may benefit patients with metastatic prostate cancer sooner - Medical Xpress

Thu, 06 Aug 2026 01:09:35 GMTTLX591 Antibody-Based Lutetium-177 PSMA Therapy in Metastatic CRPC - Pedro Barata - UroToday

Wed, 05 Aug 2026 10:28:25 GMTFDA Approved Pluvicto Plus ARPI for PSMA-Positive mAPMN/S Prostate Cancer - Oncodaily

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Pluvicto4 live mentions Positive4 live mentions S Prostate Cancer4 live mentions UroToday3 live mentions Excited2 live mentions See2 live mentions PSMAddition Trial Published2 live mentions Oncodaily Oncodaily2 live mentions Biochemical Recurrence After2 live mentions Prostate Cancer Treatment2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Psma.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.